ARTICLE | Clinical News
VXM01: Phase I/II data
February 18, 2013 8:00 AM UTC
Top-line data from the dose-escalation, double-blind, placebo-controlled, German Phase I/II VXM01-01-DE trial in 45 patients with locally advanced, inoperable, stage IV pancreatic cancer showed that 4...